Biomerica, Inc. (BMRA) has a negative trailing P/E of -1.5, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. Trailing earnings yield is -64.98%.
Criteria proven by this page:
Overall SharesGrow Score: 46/100 with 3/7 criteria passed.
| Year | P/E (TTM) | PEG Ratio | P/B Ratio | P/S Ratio | Dividend Yield |
|---|---|---|---|---|---|
| 2016 | -64.0 | -0.18 | 18.39 | 18.68 | - |
| 2017 | -181.8 | 4.04 | 36.80 | 28.52 | - |
| 2018 | -190.4 | -3.49 | 64.51 | 50.15 | - |
| 2019 | -69.3 | -1.31 | 41.65 | 31.89 | - |
| 2020 | -220.8 | 19.14 | 36.34 | 77.17 | - |
| 2021 | -46.8 | -0.35 | 37.75 | 48.39 | - |
| 2022 | -78.3 | 2.35 | 42.63 | 18.80 | - |
| 2023 | -21.7 | -0.56 | 13.23 | 29.06 | - |
| 2024 | -13.1 | 0.47 | 11.84 | 14.41 | - |
| 2025 | -1.4 | 0.00 | 1.71 | 1.32 | - |
| Year | EPS (Diluted) | Revenue | Net Income | Net Margin |
|---|---|---|---|---|
| 2016 | $-0.20 | $5.14M | $-1.5M | -29.2% |
| 2017 | $-0.11 | $5.79M | $-908.56K | -15.7% |
| 2018 | $-0.17 | $5.56M | $-1.47M | -26.3% |
| 2019 | $-0.26 | $5.2M | $-2.39M | -46% |
| 2020 | $-0.23 | $6.69M | $-2.34M | -34.9% |
| 2021 | $-0.54 | $7.2M | $-6.47M | -89.9% |
| 2022 | $-0.36 | $18.87M | $-4.53M | -24% |
| 2023 | $-0.50 | $5.34M | $-7.14M | -133.7% |
| 2024 | $-0.36 | $5.42M | $-5.98M | -110.4% |
| 2025 | $-2.16 | $5.31M | $-4.97M | -93.6% |
